Related Experiment Videos
Pediatric lung transplantation
1Department of Pediatrics, Cleveland Clinic Foundation, Ohio, USA.
Insights
Pediatric lung transplantation is increasingly successful for conditions like cystic fibrosis. Survival rates for children undergoing lung transplants are comparable to adults, showing promising outcomes.
Area of Science:
- Pediatric surgery
- Thoracic surgery
- Immunology
Background:
- Pediatric lung transplantation is a growing field with improving outcomes.
- Common indications include cystic fibrosis, pulmonary vascular disease, and fibrotic lung disease.
- Transplant challenges in children share similarities with adults but have unique pediatric considerations.
Purpose of the Study:
- To review the current status and outcomes of pediatric lung transplantation.
- To highlight common indications, contraindications, and complications specific to pediatric recipients.
- To discuss challenges faced by pediatric patients, particularly those with cystic fibrosis.
Main Methods:
- Review of existing literature and clinical experience in pediatric lung transplantation.
- Analysis of common indications and contraindications.
- Evaluation of post-transplant complications and survival data.
Main Results:
- Lung transplantation in children is becoming more common and successful.
- Cystic fibrosis, pulmonary vascular disease, and fibrotic lung disease are primary indications.
- Post-transplant lymphoproliferative disorder and airway issues may be more frequent in children.
Conclusions:
- Pediatric lung transplantation offers survival rates comparable to adults (approx. 65% at 1 year, 69% at 2 years).
- Cystic fibrosis patients encounter specific challenges, including infections and comorbidities.
- Continued experience is enhancing the success of pediatric lung transplants.
Abstract:
Pediatric lung transplantation is becoming more common, and with increasing experience there is increasing success. The most common indications for considering lung transplantation are cystic fibrosis, pulmonary vascular disease (usually due to congenital heart disease), and fibrotic lung disease. The contraindications and complications are similar to adult transplant patients, although post-transplant lymphoproliferative disease and airway complications may occur more frequently. The patients with cystic fibrosis face additional obstacles to the success of transplantation: airway colonization with Gram-negative organisms, pancreatic insufficiency, glucose intolerance, and osteoporosis. The survival for children is comparable to adults, reaching about 65% at 1 year, and 69% at 2 years.